The Discounted Cash Flow (DCF) valuation of China SXT Pharmaceuticals Inc (SXTC) is (3.67) USD. With the latest stock price at 1.20 USD, the upside of China SXT Pharmaceuticals Inc based on DCF is -406.0%.
Based on the latest price of 1.20 USD and our DCF valuation, China SXT Pharmaceuticals Inc (SXTC) is a sell. selling SXTC stocks now will result in a potential gain of 406.0%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 6.7% | 6.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (30.81) - (1.71) | (3.67) |
| Upside | -2667.7% - -242.8% | -406.0% |